TCI マネジメント

マネジメント基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Yung-Hsiang Lin

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	7.5yrs
CEOの所有権	1.2%
経営陣の平均在職期間	3.5yrs
取締役会の平均在任期間	5.2yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Yung-Hsiang Lin

7.5yrs

在職期間

Mr. Yung-Hsiang Lin serves as the Chairman, CEO & General Manager of TCI Co., Ltd and has been its Director since May 2017. He holds Bachelor Degree in Botany from National Chung Hsing University. He was a...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Yung-Hsiang Lin	Chairman	no data	データなし	1.21% NT$ 177.8m
Chien Tien Huang	Assistant Manager	no data	データなし	データなし
Chen-Chia Huang	Head of Corporate Governance	5.1yrs	データなし	データなし
Wei-Chiang Chi	Head of Audit Department	10.1yrs	データなし	データなし
Tung- Wei Li	US Regional Managing Director	2.7yrs	データなし	データなし
Ching-Ting Chen	Head of Research and Design Center and Institutional Director	4.8yrs	データなし	0.059% NT$ 8.7m
Chiao-Ling Li	Head of Talent Development Center	2.6yrs	データなし	データなし
Hao-Chun Wang	Head of Strategic Intelligence Center	2.6yrs	データなし	データなし
Chiu- Yueh Li	Head of Precise iManufacturing	2.6yrs	データなし	データなし
Juen-Ying Chiou	Head of Stock Service Team	4.3yrs	データなし	データなし

3.5yrs

平均在職期間

経験豊富な経営陣: 8436の経営陣は経験豊富であると考えられます ( 3.5年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Yung-Hsiang Lin	Chairman	7.5yrs	データなし	1.21% NT$ 177.8m
Ching-Ting Chen	Head of Research and Design Center and Institutional Director	less than a year	データなし	0.059% NT$ 8.7m
Sung-Yuan Liao	Independent Director	7.5yrs	データなし	データなし
Chen-Yi Kao	Independent Director	7.5yrs	データなし	データなし
Pi-Shu Li	Representative Director	5.2yrs	データなし	0.0011% NT$ 164.2k
Shih-Ming Li	Independent Director	4.4yrs	データなし	データなし
Shu-Min He	Independent Director	4.4yrs	データなし	0.00085% NT$ 124.6k

5.2yrs

平均在職期間

経験豊富なボード: 8436の取締役会は経験豊富であると考えられます ( 5.2年の平均在任期間)。

TCI マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

TCI Co., Ltd. Approves the By-Election of Ching-Ting Chen as Institutional Director

TCI Co., Ltd., Annual General Meeting, Jun 25, 2024

Insufficient new directors

TCI Co., Ltd. Appoints Representative of the Legal Person as Director

TCI Co., Ltd. Announces Executive Changes

TCI Co., Ltd. Appoints Members of the Risk Management Committee

Recent updates

Consensus EPS estimates fall by 20%

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 13%

TCI Co., Ltd. Unveils Promising GLP-1 Formula Clinical Trial Results for Advanced Weight Management

TCI Co., Ltd. to Report Q2, 2024 Results on Jul 30, 2024

Dividend of NT$7.00 announced

New major risk - Revenue and earnings growth

TCI Co., Ltd. Approves the By-Election of Ching-Ting Chen as Institutional Director

Consensus EPS estimates increase by 16%

First quarter 2024 earnings: EPS exceeds analyst expectations

Now 21% overvalued

TCI Co., Ltd. Board Approves Dividend Distribution for the Year Ended December 31, 2023

TCI Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

TCI Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

Consensus revenue estimates fall by 12%

Full year 2023 earnings: EPS and revenues miss analyst expectations

TCI Co., Ltd., Annual General Meeting, Jun 25, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

TCI Co., Ltd. Unveils Weight Loss Formula at SupplySide West 2023

Upcoming dividend of NT$5.02 per share at 4.8% yield

TCI Co., Ltd. Announces Cash Dividend, Payable on August 22, 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

TCI Introduces Vecollal

TCI Introduces Vecollal

Insufficient new directors

TCI Co., Ltd. Appoints Representative of the Legal Person as Director

Consensus EPS estimates fall by 26%

TCI Co., Ltd. Announces Cash Dividend for the Year Ended December 31, 2022

Now 22% undervalued

Now 20% undervalued

Price target increased by 11% to NT$179

Consensus forecasts updated

Price target increased to NT$177

Investor sentiment improved over the past week

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

TCI Co., Ltd. Announces Executive Changes

Consensus EPS estimates fall by 31%

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of NT$8.92 per share

TCI Co., Ltd. Approves Cash Dividend, Payable on August 18, 2022

Price target decreased to NT$183

TCI Co., Ltd. Appoints Members of the Risk Management Committee

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Price target decreased to NT$197

TCI Co., Ltd., Annual General Meeting, Jun 29, 2022

Price target decreased to NT$197

Consensus EPS estimates fall by 13%

Price target decreased to NT$258

Price target decreased to NT$278

Price target decreased to NT$283

Third quarter 2021 earnings released: EPS NT$4.02 (vs NT$4.23 in 3Q 2020)

Upcoming dividend of NT$8.88 per share

Second quarter 2021 earnings released: EPS NT$4.19 (vs NT$4.50 in 2Q 2020)

Investor sentiment improved over the past week

TCI Co., Ltd. (TPEX:8436) entered into a memorandum of understanding to acquire US manufacturing operations from NewAge, Inc. (NasdaqCM:NBEV) for $3.5 million.

Head of Finance Department & CFO Chia- Chi Li has left the company

Price target increased to NT$249

Price target increased to NT$240

First quarter 2021 earnings released: EPS NT$3.25 (vs NT$3.13 in 1Q 2020)

Is TCI Co., Ltd. (GTSM:8436) A Smart Choice For Dividend Investors?

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$15.69 (vs NT$17.02 in FY 2019)

Analysts lower EPS estimates to NT$15.17

TCI Co., Ltd. (GTSM:8436) made an offer to acquire 30% stake in Maxigen Biotech Inc. (TSEC:1783) for approximately TWD 600 million.

Price target lowered to NT$235

Full year 2020 earnings released: EPS NT$15.69 (vs NT$17.02 in FY 2019)

Revenue and earnings miss expectations

マネジメント基準チェック /24